Stage I Adult Hodgkin Lymphoma

13 clinical trials · Condition

Record	Firm	Date
HIV-Resistant Gene Modified Stem Cells and Chemotherapy in Treating Patients With Lymphoma With HIV Infection (NCT02343666)	Fred Hutchinson Cancer Center	2016-08-15
Lenalidomide and Combination Chemotherapy (DA-EPOCH-R) in Treating Patients With MYC-Associated B-Cell Lymphomas (NCT02213913)	University of Chicago	2014-07-29
Dose Monitoring of Busulfan and Combination Chemotherapy in Hodgkin or Non-Hodgkin Lymphoma Undergoing Stem Cell Transplant (NCT01959477)	Case Comprehensive Cancer Center	2014-03-01
Vorinostat, Tacrolimus, and Methotrexate in Preventing GVHD After Stem Cell Transplant in Patients With Hematological Malignancies (NCT01789255)	National Cancer Institute (NCI)	2013-06-01
Brentuximab Vedotin + Rituximab as Frontline Therapy for Pts w/ CD30+ and/or EBV+ Lymphomas (NCT01805037)	Northwestern University	2013-03-05
Vaccine Therapy in Preventing Cytomegalovirus Infection in Patients With Hematological Malignancies Undergoing Donor Stem Cell Transplant (NCT01588015)	City of Hope Medical Center	2012-10-29
Deferasirox in Treating Iron Overload Caused By Blood Transfusions in Patients With Hematologic Malignancies (NCT01273766)	Wake Forest University Health Sciences	2011-01-01
Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant (NCT01199562)	City of Hope Medical Center	2010-12-01
Lopinavir and Ritonavir in Improving Immune Response to Vaccines in Patients With Complete Remission Following A Bone Marrow Transplant for Hodgkin Lymphoma (NCT01165645)	Mayo Clinic	2010-11-01
Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer (NCT00489203)	Fred Hutchinson Cancer Center	2007-04-01
Bortezomib, Ifosfamide, and Vinorelbine Tartrate in Treating Young Patients With Hodgkin's Lymphoma That is Recurrent or Did Not Respond to Previous Therapy (NCT00381940)	National Cancer Institute (NCI)	2007-01-01
Fenretinide and Rituximab in Treating Patients With B-Cell Non-Hodgkin Lymphoma (NCT00288067)	National Cancer Institute (NCI)	2005-10-01
Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer (NCT00112593)	Fred Hutchinson Cancer Center	1999-11-01

Track Stage I Adult Hodgkin Lymphoma automatically

Every clearance here is in the API, with alerts when new ones post.